Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES AUROBINDO PHARMA ALKEM LABORATORIES/
AUROBINDO PHARMA
 
P/E (TTM) x 29.6 12.1 243.5% View Chart
P/BV x 4.6 1.2 380.6% View Chart
Dividend Yield % 1.0 1.8 57.6%  

Financials

 ALKEM LABORATORIES   AUROBINDO PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
AUROBINDO PHARMA
Mar-22
ALKEM LABORATORIES/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs4,0681,064 382.4%   
Low Rs2,671584 457.2%   
Sales per share (Unadj.) Rs889.4400.3 222.2%  
Earnings per share (Unadj.) Rs140.545.7 307.4%  
Cash flow per share (Unadj.) Rs166.064.9 255.6%  
Dividends per share (Unadj.) Rs34.009.00 377.8%  
Avg Dividend yield %1.01.1 92.4%  
Book value per share (Unadj.) Rs722.4419.4 172.2%  
Shares outstanding (eoy) m119.57585.94 20.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.82.1 184.1%   
Avg P/E ratio x24.018.0 133.0%  
P/CF ratio (eoy) x20.312.7 160.0%  
Price / Book Value ratio x4.72.0 237.4%  
Dividend payout %24.219.7 122.9%   
Avg Mkt Cap Rs m402,868482,799 83.4%   
No. of employees `000NANA-   
Total wages/salary Rs m19,62734,509 56.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,342234,555 45.3%  
Other income Rs m1,6273,226 50.4%   
Total revenues Rs m107,968237,781 45.4%   
Gross profit Rs m20,38042,566 47.9%  
Depreciation Rs m3,04011,265 27.0%   
Interest Rs m524486 107.7%   
Profit before tax Rs m18,44334,040 54.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6407,256 22.6%   
Profit after tax Rs m16,80326,784 62.7%  
Gross profit margin %19.218.1 105.6%  
Effective tax rate %8.921.3 41.7%   
Net profit margin %15.811.4 138.4%  
BALANCE SHEET DATA
Current assets Rs m84,354181,227 46.5%   
Current liabilities Rs m48,05381,560 58.9%   
Net working cap to sales %34.142.5 80.3%  
Current ratio x1.82.2 79.0%  
Inventory Days Days4225 167.5%  
Debtors Days Days6562 103.6%  
Net fixed assets Rs m43,245155,104 27.9%   
Share capital Rs m239586 40.8%   
"Free" reserves Rs m86,134245,174 35.1%   
Net worth Rs m86,373245,760 35.1%   
Long term debt Rs m942,492 3.8%   
Total assets Rs m127,599336,331 37.9%  
Interest coverage x36.271.0 51.0%   
Debt to equity ratio x00 10.7%  
Sales to assets ratio x0.80.7 119.5%   
Return on assets %13.68.1 167.5%  
Return on equity %19.510.9 178.5%  
Return on capital %21.913.9 157.7%  
Exports to sales %18.731.1 60.3%   
Imports to sales %011.9 0.0%   
Exports (fob) Rs m19,92472,862 27.3%   
Imports (cif) Rs mNA27,965 0.0%   
Fx inflow Rs m19,92477,245 25.8%   
Fx outflow Rs m3,91131,524 12.4%   
Net fx Rs m16,01345,721 35.0%   
CASH FLOW
From Operations Rs m11,11050,165 22.1%  
From Investments Rs m-14,351-32,116 44.7%  
From Financial Activity Rs m3,796-29,693 -12.8%  
Net Cashflow Rs m580-11,674 -5.0%  

Share Holding

Indian Promoters % 57.1 48.8 117.2%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 19.8 38.0 52.0%  
FIIs % 5.7 20.7 27.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 48.2 89.0%  
Shareholders   84,104 359,684 23.4%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   CIPLA    LUPIN    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Aurobindo Pharma Share Price Performance

Period ALKEM LABORATORIES Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 0.99% -2.98% -1.41%
1-Month 13.10% -8.70% -0.59%
1-Year -17.73% -30.48% -12.72%
3-Year CAGR 19.83% -6.31% 20.60%
5-Year CAGR 11.86% -6.66% 10.61%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.1% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

Aurobindo Pharma paid Rs 9.0, and its dividend payout ratio stood at 19.7%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

5 Reasons Why Sensex Plunged 954 Points Today(Closing)

Indian share markets continued their downtrend throughout the session today and ended deep in the red.